Purchase Order 75N93023P01015
Award Date 8/2/23
Potential Completion Date 9/29/23
Potential Value $33K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA 20164, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,920.00 firm fixed-price purchase order contract to ABI Scientific Inc., a minority-owned and Asian-Pacific American-owned for-profit organization. The contract was awarded on September 24, 2018, with a completion date of October 24, 2018, and the place of performance is Bethesda, Maryland. This contract does not have a set-aside designation.
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $29,859.00 fixed-price delivery order is for the manufacture of master cell banks to support pandemic preparedness and the COVID-19 response. The ultimate completion date is April 15, 2025. ABL is an experienced contractor that has been awarded multiple Indefinite Delivery...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $16,345.50 purchase order to Biointron Biological USA Inc. for antibody expression services. As a firm fixed price contract, Biointron will provide the requested antibody expression services to NIH/NIAID at Metuchen, New Jersey from September 19, 2023 through December 29, 2023. No subcontractors or set aside designations were indicated. NIAID conducts and...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to ABI Scientific Inc., a minority-owned and Asian-Pacific American-owned for-profit organization. The contract is for the delivery of 100 units of Adherent Cell Expression Media 250 ML at a total potential value of $12,340.00. The contract was awarded on January 30, 2018, with a completion date of January 30, 2019....
- This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract, valued at $4,328,663.00, is for expertise in the product development lifecycle, including services such as cGMP manufacturing of vaccines and biologics, process development, analytical testing, stability studies, and project management for infectious...
- This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $1,826,332.06, is for the provision of preclinical development support services related to the NIAID's infectious disease research and product development...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $63,396.00 firm fixed-price purchase order to Life Technologies Corporation, doing business as Thermo Fisher Scientific, for the procurement of Freestyle 293 Expression Medium and EXPI293 Expression Medium. These specialized cell culture media products are critical for protein and antibody production in vaccine development research targeting HIV-1, SARS-CoV-2, and other viruses at the NIAID Vaccine Research Center. The...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,950.00 firm fixed price purchase order to Bio X Cell, LLC, a for-profit limited liability company. The contract is for the delivery of BIO X CELL AB 1000MG and has an ultimate completion date of August 7, 2017. This award supports COVID-19 research as well as research on vaccines and infectious diseases at the NIAID, and Bio X Cell has...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $31,202.00 fixed-price level of effort contract is for process development of vaccine candidates, including for SARS-CoV-2. The award has an ultimate completion date of April 15, 2025. ABL has been awarded multiple indefinite...